27 March 2014 - Deborah Wilkes
Archived
Stada Arzneimittel has cut its sales and profits forecasts for 2014 in the wake of the crisis in the Ukraine, but its strategy in Eastern Europe will remain the same.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.